The delay in accepting French research was not merely another episode of international rivalry, they felt, but a development that would cost science its most crucial weapon in fighting the epidemic: time. And they needed time to start testing anti-viral drugs for treating AIDS, to develop a widely available antibody test, to begin blood testing and serious control measures.
